Evidence map›Paper›PMID 33764132›Full record

ArticleAfrican journal of primary health care & family medicine2021

Suboptimal control for patients with type 2 diabetes in the Central Chronic Medicine Dispensing programme in South Africa.

Patrick Ngassa Piotie, Elizabeth M Webb, Paul Rheeder

Abstract read
In one paragraph

Article in African journal of primary health care & family medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Quality of care provided to patients with type 2 diabetes mellitus in Tshwane, South Africa.African journal of primary health care & family medicine · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Compliance of medical practitioners with diabetic treatment guidelines in West Rand, Gauteng.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2023
    Article
  13. Article
  14. Measuring the impact of community-based interventions on type 2 diabetes control during the COVID-19 pandemic in Cape Town - A mixed methods study.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Patrick Ngassa PiotieSchool of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria. patrick.ngassapiotie@up.ac.za.
Elizabeth M Webb
Paul Rheeder

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn South Africa, the Central Chronic Medicine Dispensing and Distribution (CCMDD) programme allows stable patients with non-communicable diseases, including type 2 diabetes mellitus (T2DM), to collect their medication from a pick-up location near their home, thus avoiding long waiting times and travel expenses. The CCMDD programme aims at improving patient retention and adherence through better access to medicines, resulting in better health outcomes.

aimWe assessed whether patients with T2DM enrolled in CCMDD achieved the recommended targets for glycaemic, blood pressure (BP) and lipid control.

settingCity of Tshwane, South Africa.

methodsWe reviewed the records of 198 T2DM patients enrolled in CCMDD and assessed their control of haemoglobin A1c (HbA1c), BP and lipids.

resultsMost of the records reviewed belonged to women (64.7%), African (89.9%), hypertensive (82.7%) and to patients exclusively on oral antidiabetic agents (98.5%). Patients were, on average, 57.7 (s.d. = 12.1) years old and had participated in the CCMDD programme for, on average, 2 years. The mean HbA1c was 8% (s.d. = 2). Glycaemic control was achieved by only 29.2% of patients, and 49% of patients had HbA1c between 7% and 9%. Ninety-three patients (66%) had achieved the total cholesterol target, 57.4% achieved BP targets and 6.9% had achieved the low-density lipoprotein cholesterol target.

conclusionA small group of patients achieved the targets for glycaemic, BP and lipid control. Despite improved accessibility to medication, the CCMDD is not synonymous of improved clinical outcomes. Future research should ascertain the factors associated with suboptimal control for these patients.

Indexed as

Health Services AccessibilityProcess Assessment, Health CareAdolescentAdultAgedBlood GlucoseDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHumansHypoglycemic AgentsMaleMedical AuditMiddle AgedProgram EvaluationSouth AfricaBlood GlucoseGlycated HemoglobinHypoglycemic AgentsauditCCMDD programmeglucose controlprimary health careSEMDSA guidelinestype 2 diabetes

Identifiers

PMID33764132
PMCPMC8063568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.